Last reviewed · How we verify

NCT06946654: GA

Geriatric Assessment (GA) for Elderly Patients Undergoing Allo-HSCT

Not yet recruiting Last updated 11 May 2025
What this trial tests

trial testing Geriatric Assessment in Elderly in 176 participants. Not yet recruiting.

Timeline
20 May 2025
Primary endpoint
31 March 2027
31 March 2027

Quick facts

Lead sponsorPeking University People's Hospital
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment176
Start date20 May 2025
Primary completion31 March 2027
Estimated completion31 March 2027
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Peking University People's Hospital

Who can join

55 and older, any sex, with Elderly or Geriatric Assessment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This comprehensive, multidimensional evaluation assesses patient-related factors, disease-related factors, donor-related factors, and treatment-related factors. The study aims to identify potential risk factors influencing transplant outcomes in elderly patients and enhance the outcomes of allo-HSCT.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Geriatric Assessment

Trials testing the same drug.

Other recruiting trials for Elderly

Currently open trials in the same condition.

Other Peking University People's Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06946654.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing